Managing ADHD Medication: Navigating the Transition from Childhood to Adulthood

Navigating the transition from childhood ADHD to adult ADHD

There’s a misconception that the treatment of the neurodevelopmental disorder Attention Deficit Hyperactivity Disorder (ADHD) stops in adolescence. A large body of evidence shows that ADHD can have serious consequences in adulthood too.

Adult ADHD can be treated and managed effectively with pharmacological, i.e. ADHD medication, and non-pharmacological interventions, e.g. balanced diet, exercise, healthy daily routine, relaxation, and life coaching.

Research on ADHD transition and ADHD medication

Please have a read of the helpful and revealing BJPsychOpen Editorial of 6th April 2020 below. It’s titled “Regional analysis of UK primary care prescribing and adult service referrals for young people with attention-deficit hyperactivity disorder: from little to very little” and was written by Samuele Cortese, Professor of Child & Adolescent Psychiatry at the University of Southampton and a member of the European ADHD Guidelines group (EAGG). In this insightful piece, Professor Cortese delves into the pressing issues surrounding the transition of young individuals with attention-deficit hyperactivity disorder (ADHD) from childhood into adulthood, a critical phase that often presents numerous challenges and obstacles. He highlights the growing problems of ADHD transition and its effective treatment from adolescence to adulthood, emphasising the need for improved strategies and resources to ensure that these young people receive the appropriate care as they navigate this significant life change.

In the editorial, Cortese provides a comprehensive overview of the current state of ADHD management within the UK, particularly focusing on the disparities in prescribing practices across different regions. He discusses the alarming trend of insufficient referrals to adult services for those diagnosed with ADHD, pointing out that many young adults are left without adequate support and treatment as they age out of pediatric care. This gap in services can lead to detrimental outcomes, including increased rates of comorbid psychiatric disorders, substance abuse, and difficulties in maintaining employment and relationships.

Furthermore, the editorial sheds light on the importance of a coordinated approach to ADHD management that spans from childhood through adolescence and into adulthood. Cortese advocates for the implementation of standardised protocols that can guide healthcare providers in making informed decisions regarding medication management and referrals to specialised services. He stresses that a proactive approach is necessary to address the unique needs of adolescents with ADHD, ensuring they are not only treated effectively but also supported in their transition to adult life.

Overall, this editorial serves as a crucial call to action for healthcare professionals, policymakers, and educators alike, urging them to recognise the significance of seamless ADHD care during the transition years. By fostering a better understanding of the complexities involved in ADHD treatment and advocating for enhanced service provision, we can work towards improving the quality of life for young people affected by this condition. It is essential that we take Professor Cortese's insights seriously and strive to create a more inclusive and supportive healthcare environment for those living with ADHD.

https://www.ukaan.org/getfile/documents/Cortese_BJPO_2020.pdf

At IamPsychiatry, we can support and manage this transition safely and effectively. Email driqbal@IamPsychiatry.com or call 0800 779 7800 if you're having problems with your ADHD treatment or ADHD medication.